Clinical Trial: Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Light Chain (AL) Amyloidosis
Study Type: INTERVENTIONAL
Official Title: Phase 1b Dose Expansion Study of NXC-201 for the Treatment of Patients With Relapsed or Refractory AL Amyloidosis
Brief Summary:
Open-label Phase 1b Dose Escalation/Dose Expansion study exploring the safety and efficacy of NXC-201 in patients with relapsed or refractory light chain amyloidosis (AL).
Read more